These B cells promote T-cell-dependent antitumor immunity, thereby enhancing the efficacy of chemotherapy.250 Additionally, Furthermore, pathological antibodies secreted by B cells bind to the HSPA4 receptor on the surface of tumor cell membranes, thereby initiating downstream signaling pathways that activate the NF-κB pathway in tumor cells. The gene discussed is NFKB1; the disease is neoplasm.